Selank and semax on TikTok: separating hype from human data

What did @redheadedpepchild actually say?

The creator is answering a viewer question about whether selank and semax should be taken at different times of day. Their short answer: yes, that's technically the recommendation, but they personally mix both into one syringe and inject them together in the morning. They acknowledge the conventional logic, which is that selank is calming and semax is stimulating, so splitting them makes theoretical sense. But they also admit that forgetting a nighttime dose tanked their mood, so convenience won over protocol.

They also mention taking weekends off and occasionally skipping doses when pressed for time. This is an honest, anecdotal account. They're not claiming to be a clinician. They're explicit that this is a personal experiment. That framing matters when evaluating what follows.

Does the science back this up?

Barely, and not in the way the video implies. The problem is that neither selank nor semax has robust human clinical trial data supporting specific dosing windows, let alone co-administration timing. What exists is thin and mostly Russian.

Selank is a synthetic heptapeptide derived from tuftsin. It has shown anxiolytic effects in small Russian trials, with Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reporting reduced anxiety and improved memory in patients with generalized anxiety disorder. The mechanism involves modulation of GABA receptors and possible effects on brain-derived neurotrophic factor. None of that research specifies optimal time of administration relative to other peptides.

Semax, a synthetic ACTH analogue, has similarly limited data. Dolotov et al. (2006, Journal of Neurochemistry) found it increased BDNF expression in rodents. A small number of Russian clinical studies suggest cognitive benefits in stroke patients. Again, nothing published in peer-reviewed Western journals addresses co-administration with selank or optimal dosing windows in healthy individuals.

The idea that selank is calming and semax is stimulating is a reasonable pharmacological inference. But inferring that they therefore antagonize each other when taken together is a bigger leap than the evidence supports.

What did they get wrong (or right)?

They got the general pharmacological framing roughly right. Selank does have anxiolytic properties. Semax does appear to have nootropic and stimulating effects. Treating them as functionally different in terms of their nervous system targets is not a bad lay summary.

What they got wrong, or at least oversimplified, is the claim that taking them separately means they won't be "competing with each other for their benefits." There's no published evidence that these two peptides compete for the same receptors or pathways in a meaningful way when co-administered. One is primarily GABAergic and immune-modulating. The other works through ACTH-related signaling. The concern about competition is speculative at best.

They also normalize self-injection and compounding without flagging that the quality, purity, and dosing accuracy of research-grade peptides vary enormously depending on the source. That's not a small omission. Contaminated or misdosed peptides are a real risk in this space, and the casual tone here doesn't help users assess that risk.

Credit where it's due: they do not overstate their own authority. "That's just my personal anecdote and do with it" is an appropriate disclaimer. More creators should say that.

What should you actually know?

If you're considering selank or semax, a few things deserve more attention than they got in this video.

• Both peptides are not FDA-approved for any indication. They exist in a research and compounding grey zone. That has real implications for quality control.
• The anxiolytic framing for selank is the most evidence-backed claim in this video, but the evidence is still limited to small trials, mostly in Russian journals, with limited independent replication.
• The timing recommendations circulating in peptide communities are largely derived from pharmacological inference and self-experimentation, not clinical studies. The video is honest about this, even if implicitly.
• Mood changes from skipping doses, which the creator mentions directly, could reflect psychological expectation effects as much as pharmacological ones. Placebo response in nootropic and anxiolytic peptide users is likely significant and rarely discussed.
• Anyone experiencing meaningful mood drops tied to peptide use should be speaking to a licensed clinician, not adjusting their peptide schedule based on TikTok feedback loops.

The bigger issue here is not this one video. It's that the entire framing of self-experimentation with injectable peptides as a low-stakes hobby is spreading faster than any evidence base can support it.